ABSTRACT Complexes of high-molecular-weight RNA and reverse transcriptase (RNA-dependent DNA nucleotidyltransferase) have been detected in 14 (77.8%) of I8 spleens from patients with Hodgkin's disease and in all samples tested of peripheral leukocytes and spleens from leukemic patients. The enzyme and its template are localized in a particle having a density between 1.16 and 1.19 g/ml. These observations describe characteristic features of RNA tumor viruses.
Two characteristic components of type-C viruses have been detected in human neoplasias: high-molecular-weight (HMW) RNA having sequence homologies to those of some murine and primate type-C viruses (1-7); and RNA-dependent DNA polymerase (reverse transcriptase) having biochemical characteristics indistinguishable from those of viral reverse transcriptase and immunologically related to the enzyme of type-C primate and murine RNA tumor viruses (8) (9) (10) (11) (12) .
To establish whether the RNA molecule identified in tumors is associated with a reverse transcriptase in a particle possessing other features of complete or incomplete virus particles (13), Schlom and Spiegelman (14) devised a concomitant test, "simultaneous detection," for both the enzyme and its template.
The simultaneous detection test was applied to human breast cancer (1, 2) , human leukemic cells (8, 17) , and human lymphomas (16) . The results obtained indicated that one can find a HMW RNA associated with a reverse transcriptase in a particle possessing a density between 1.16 and 1.19 g/ml.
We report here the detection of a complex of HMW RNA and reverse transcriptase in tissues of patients with Hodgkin's disease and patients with leukemia. The enzyme and its RNA template are localized in h particle having a density characteristic of the RNA tumor viruses.
MATERIALS AND METHODS
The experiments described involve: (a) spleens from 18 patients with Hodgkin's disease; (b) leukocytes from five leukemic patients; (c) spleens from eight leukemic patients; and (d) five normal spleens.
The simultaneous detection test was performed according to Spiegelman and his associates (8, 13, 15 After incubation at 370 for 15 min, the reaction mixture was adjusted to 0.2 M NaCl and 1% sodium dodecyl sulfate, and then deproteinized by extraction with an equal volume of a phenol-cresol (7:1) mixture containing 8-hydroxyquinoline (3.7 g per 100 ml of mixture). The aqueous phase was layered on a 10-30% gradient of glycerol in TNE buffer and centrifuged in a Spinco SW41 rotor at 40,000 rpm for 180 min at 20.
When ribonuclease sensitivity was tested, one aliquot of the product was run on the gradient as a control and the other was pretreated with 20 hemocytoblastic leukemia ( Fig. 2A ) and in the spleens from two patients with chronic myelogenous leukemia ( Fig. 2B and C) . Additional peaks (Fig. 2C ) were observed at positions 52 S and 35 S (16) . In certain samples, the DNA-RNA complex was present at position 35 S (Fig. 2D) . 
